Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Jun;87(12):4473–4475. doi: 10.1073/pnas.87.12.4473

Osteopontin--a possible anchor of osteoclasts to bone.

F P Reinholt 1, K Hultenby 1, A Oldberg 1, D Heinegård 1
PMCID: PMC54137  PMID: 1693772

Abstract

A key event in bone resorption is the binding of osteoclasts to the mineral matrix of bone surfaces. A candidate for mediating this binding is osteopontin, a major cell- and hydroxyapatite-binding protein synthesized by osteoblasts. In support of this hypothesis is the fact that the synthesis of osteopontin is stimulated by calcitriol (1,25-dihydroxy-vitamin(D3), a substance that induces bone resorption. The present study demonstrates that osteopontin is highly enriched at regions of the bone surface where osteoclasts are anchored. Furthermore, the vitronectin receptor, which has known specificity for osteopontin, is shown preferentially localized at the corresponding area of the osteoclast plasma membrane. The results thus support the hypothesis that osteoclasts when resorbing bone are anchored by osteopontin bound both to the mineral of bone matrix and to a vitronectin receptor on the osteoclast plasma membrane.

Full text

PDF
4473

Images in this article

4473Image
on p.4473
4474Image
on p.4474
4474Image
on p.4474

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chambers T. J., Fuller K., Darby J. A., Pringle J. A., Horton M. A. Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner. 1986 Apr;1(2):127–135. [PubMed] [Google Scholar]
  2. Davies J., Warwick J., Totty N., Philp R., Helfrich M., Horton M. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol. 1989 Oct;109(4 Pt 1):1817–1826. doi: 10.1083/jcb.109.4.1817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Franzén A., Heinegård D. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J. 1985 Dec 15;232(3):715–724. doi: 10.1042/bj2320715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Göthlin G., Ericsson J. L. The osteoclast: review of ultrastructure, origin, and structure-function relationship. Clin Orthop Relat Res. 1976 Oct;(120):201–231. [PubMed] [Google Scholar]
  5. Holtrop M. E., King G. J. The ultrastructure of the osteoclast and its functional implications. Clin Orthop Relat Res. 1977 Mar-Apr;(123):177–196. [PubMed] [Google Scholar]
  6. JEE W. S., NOLAN P. D. ORIGIN OF OSTEOCLASTS FROM THE FUSION OF PHAGOCYTES. Nature. 1963 Oct 19;200:225–226. doi: 10.1038/200225a0. [DOI] [PubMed] [Google Scholar]
  7. Lucht U. Osteoclasts and their relationship to bone as studied by electron microscopy. Z Zellforsch Mikrosk Anat. 1972;135(2):211–228. doi: 10.1007/BF00315127. [DOI] [PubMed] [Google Scholar]
  8. Mark M. P., Prince C. W., Oosawa T., Gay S., Bronckers A. L., Butler W. T. Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. J Histochem Cytochem. 1987 Jul;35(7):707–715. doi: 10.1177/35.7.3295029. [DOI] [PubMed] [Google Scholar]
  9. Nomura S., Wills A. J., Edwards D. R., Heath J. K., Hogan B. L. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol. 1988 Feb;106(2):441–450. doi: 10.1083/jcb.106.2.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Oldberg A., Franzén A., Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819–8823. doi: 10.1073/pnas.83.23.8819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Oldberg A., Franzén A., Heinegård D., Pierschbacher M., Ruoslahti E. Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem. 1988 Dec 25;263(36):19433–19436. [PubMed] [Google Scholar]
  12. Oldberg A., Franzén A., Heinegård D. The primary structure of a cell-binding bone sialoprotein. J Biol Chem. 1988 Dec 25;263(36):19430–19432. [PubMed] [Google Scholar]
  13. Oldberg A., Jirskog-Hed B., Axelsson S., Heinegård D. Regulation of bone sialoprotein mRNA by steroid hormones. J Cell Biol. 1989 Dec;109(6 Pt 1):3183–3186. doi: 10.1083/jcb.109.6.3183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Preissner K. T. The role of vitronectin as multifunctional regulator in the hemostatic and immune systems. Blut. 1989 Nov;59(5):419–431. doi: 10.1007/BF00349063. [DOI] [PubMed] [Google Scholar]
  15. Prince C. W., Butler W. T. 1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res. 1987 Sep;7(4):305–313. doi: 10.1016/s0174-173x(87)80036-5. [DOI] [PubMed] [Google Scholar]
  16. Rodan G. A., Martin T. J. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int. 1981;33(4):349–351. doi: 10.1007/BF02409454. [DOI] [PubMed] [Google Scholar]
  17. Suzuki S., Oldberg A., Hayman E. G., Pierschbacher M. D., Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J. 1985 Oct;4(10):2519–2524. doi: 10.1002/j.1460-2075.1985.tb03965.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES